David J. Madar

A Convergent Synthetic Route to (+)-Dynemicin A and Analogs of Wide Structural Variability

Andrew G. Myers, Norma J. Tom, Mark E. Fraley et al. · Journal of the American Chemical Society · 1997 · 208 citations

Bioorganic Chemistry, Engineering, Isobenzofuran 107 +23

Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity

Milan Bruncko, Le Wang, George S. Sheppard et al. · Journal of Medicinal Chemistry · 2015 · 150 citations · Full text

Drug Target, Mcl-1 Inhibitors, High Throughput +23

3,5-Bis(trifluoromethyl)pyrazoles:  A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djurić, Nwe Y. BaMaung, Anwer Basha et al. · Journal of Medicinal Chemistry · 2000 · 120 citations

Molecular Regulation, Immunology, Pharmacotherapy +18

Synthesis of (+)-dynemicin A and analogs of wide structural variability: establishment of the absolute configuration of natural dynemicin A

Andrew G. Myers, Mark E. Fraley, Norma J. Tom et al. · Chemistry & Biology · 1995 · 83 citations · Full text

Absolute Configuration, Biochemistry, Natural Dynemicin A +5

Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors

Zhonghua Pei, Xiaofeng Li, Kenton L. Longenecker et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +14